BioSpace News Archive

Battelle has honored Satya Chauhan as its Inventor of the Year and Kavitha Dasu as its most recent Emerging Scientist.

Week 8 (May 11 to 13) results from Sermo’s COVID-19 Real Time Barometer with 4,756 physicians reveal COVID-19 treatment patterns among frontline physicians. In total, Sermo’s Barometer study includes over 42,900 survey interviews in 31 countries including the United States, Canada, United Kingdom, France, Brazil, Russia, China, Japan and Australia. Complete data published to date and study methodology can be found here.

Challenges presented by the COVID-19 pandemic can be even more stressful and overwhelming for people living with chronic illnesses.

Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today released details of several upcoming scientific presentations that highlight the power of Intabio’s Blaze system.

Olympus®, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, brings together three leading pulmonologists from across the globe in a discussion around the practice of bronchoscopy in the era of COVID-19. Profs. Felix Herth and Stefano Gasparini , and Dr. Gerard Silve

Versant Health’s Elizabeth Klunk, Senior Vice President of Medical Management, was named the winner of a Silver Stevie® Award in the “Lifetime Achievement - Business Services Industries” category in The 18th Annual American Business Awards®.

Montefiore Health System and Albert Einstein College of Medicine are the first sites in the nation to begin evaluating an investigational drug in two separate, FDA-approved trials: one to treat mild-to-moderate cases of COVID-19, and the other to treat severely ill COVID-19 patients.

Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present and take meetings at upcoming virtual healthcare investor conferences in May and June 2020.

The National Kidney Foundation and American Society of Nephrology join to advance the unique needs of kidney patients during COVID-19

Nanome, Inc., a virtual reality (VR) startup whose signature product is a computational chemistry software platform, has co-authored a paper describing 10 potential small molecule inhibitors targeting the SARS-CoV-2 main protease that were generated by artificial intelligence (AI)